Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.
- DOI
- 10.1016/j.ebiom.2026.106390
- Published
- 2026 Aug
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2026.106390,
title = {Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.},
author = {Bittner T and Lopera F and Rios-Romenets S and Schiffman C and Clayton D and Hibar D and Kollmorgen G and Dolton M and Poon V and Nguyen J and Giraldo-Chica M and Acosta-Baena N and Espinosa A and Villegas G and Muñoz C and Serna L and Alvarez S and Protas H and Luo J and Sohankar J and Chen Y and Ghisays V and Malek-Ahmadi M and Ashton NJ and Denkinger MN and Cai Y and Xu YR and Ostaszewski B and Selkoe DJ and Alexander RC and Quiroz YT and Su Y and Chen K and Doody RS and Langbaum JB and Tariot PN and Sink KM and Reiman EM},
year = {2026},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2026.106390},
url = {https://doi.org/10.1016/j.ebiom.2026.106390}
}RIS
TY - JOUR TI - Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial. AU - Bittner T AU - Lopera F AU - Rios-Romenets S AU - Schiffman C AU - Clayton D AU - Hibar D AU - Kollmorgen G AU - Dolton M AU - Poon V AU - Nguyen J AU - Giraldo-Chica M AU - Acosta-Baena N AU - Espinosa A AU - Villegas G AU - Muñoz C AU - Serna L AU - Alvarez S AU - Protas H AU - Luo J AU - Sohankar J AU - Chen Y AU - Ghisays V AU - Malek-Ahmadi M AU - Ashton NJ AU - Denkinger MN AU - Cai Y AU - Xu YR AU - Ostaszewski B AU - Selkoe DJ AU - Alexander RC AU - Quiroz YT AU - Su Y AU - Chen K AU - Doody RS AU - Langbaum JB AU - Tariot PN AU - Sink KM AU - Reiman EM PY - 2026 JO - EBioMedicine DO - 10.1016/j.ebiom.2026.106390 UR - https://doi.org/10.1016/j.ebiom.2026.106390 ER -
APA
T, B., F, L., S, R., C, S., D, C., D, H., G, K., M, D., V, P., J, N., M, G., N, A., A, E., G, V., C, M., L, S., S, A., H, P., J, L., J, S., Y, C., V, G., M, M., NJ, A., MN, D., Y, C., YR, X., B, O., DJ, S., RC, A., YT, Q., Y, S., K, C., RS, D., JB, L., PN, T., KM, S., & EM, R. (2026). Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106390
Source records
- pubmed · retrieved 2026-09-26T18:01:10.822Z